Further evidence on HRT and cardiac risk

摘要

Hormone replacement therapy (HRT) does not reduce the overall risk of further cardiac events in postmenopausal women who have survived a myocardial infarction, according ot the results of a major trial. Researchers found no difference in the frequency of recurrent heart attack or cardiac death at two-year follow-up among a group of some 1,000 women, aged 50-69 years, who were treated eithe rwith 2 mg estradiol valerate or placebo daily. There was also no difference in all-cause mortality between the two groups.